Physical Therapists in Monticello, KY Accepting Medicare

6 Physical Therapists found. Showing 1 - 6

Mrs. Linda J Brown, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 S Creek Dr, Suite 116, Monticello, KY 42633 Phone: 606-348-3314    Fax: 606-348-3315

Mr. Samuel M Brown, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 S Creek Dr, Ste 116, Monticello, KY 42633 Phone: 606-348-3314    Fax: 606-348-3315

Jonathan Criswell, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 S Creek Dr Ste 116, Monticello, KY 42633 Phone: 606-348-3314

Horizon Adult Health Care Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 E Michigan Ave, Monticello, KY 42633 Phone: 606-340-0001    Fax: 606-340-0002

Kimberly J Crawford Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 S Creek Dr Ste 116, Monticello, KY 42633 Phone: 606-348-3314

Wayne County Physical Therapy Clinic Physical Therapist Medicare: Medicare Enrolled Practice Location: One Southcreek Dr, Suite 116, Monticello, KY 42633 Phone: 606-348-3314    Fax: 606-348-3315

News Archive

Scientists reveal link between depression and paraventricular thalamus

Scientists from the RIKEN Brain Science Institute have shown that a mouse strain with a mutation that leads to dysfunction of mitochondria-the "powerhouses" that provide energy to cells-spontaneously undergo periodic episodes of depression-like behavior that resemble those in human. Through this research, published in Molecular Psychiatry, the scientists uncovered a link between depression and the paraventricular thalamus, a region of the brain not previously tied to depression.

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced it now has the exclusive US commercial rights to the patented compounded alkalinized lidocaine and heparin formulation ("Hep-Lido-A" or "HLA") for the treatment of interstitial cystitis ("IC"), commonly referred to as painful bladder syndrome ("PBS").

Dimerix Bioscience announces research agreement with Takeda Cambridge

Dimerix Bioscience Pty Ltd, a pre-clinical stage product company developing a pipeline of 'best in class' lead products with highly specific activity and with reduced risk of off-target effects, today announced that it has entered into a research agreement with Takeda Cambridge Limited, a UK based subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company.

Researchers map an awake-brain

There are ethical dilemmas in cases where a person is unresponsive after a major trauma but is awake within (unresponsive wakefulness syndrome) and when a person is brain dead or truly unconscious. In these cases stopping life support can be a tough decision.

Read more Medical News

› Verified 2 days ago